Page last updated: 2024-11-02

oxymetazoline and Telangiectasia, Hereditary Hemorrhagic

oxymetazoline has been researched along with Telangiectasia, Hereditary Hemorrhagic in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Telangiectasia, Hereditary Hemorrhagic: An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Poetker, DM1

Other Studies

1 other study available for oxymetazoline and Telangiectasia, Hereditary Hemorrhagic

ArticleYear
Endoscopic-guided coblation treatment of nasal telangiectasias in hereditary hemorrhagic telangiectasia: "How I do it".
    American journal of rhinology & allergy, 2017, May-01, Volume: 31, Issue:3

    Topics: Anesthesia, Local; Bevacizumab; Cautery; Electrosurgery; Endoscopy; Epistaxis; Humans; Nose; Oxymeta

2017